HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Outcomes of follicle-stimulating hormone priming and nonpriming in in vitro maturation of oocytes in infertile women with polycystic ovarian syndrome: a single-blinded randomized study.

AbstractBACKGROUND/AIMS:
Follicle-stimulating hormone (FSH) priming has been studied in in vitro matured oocytes for oocyte maturation rate, embryo quality, and pregnancy rate with discouraging results. This study aimed to initiate FSH stimulation later, i.e. on day 6, to prolong natural endometrial priming and promote oocyte maturation.
METHODS:
Forty polycystic ovarian syndrome (PCOS) patients were enrolled into a single, blinded (investigator), randomized, controlled study, and randomly allocated to group 1 (no FSH priming) or group 2 (day 6 recombinant FSH priming). Oocytes were retrieved after human chorionic gonadotropin injection on day 10. After 27 or 51 h of incubation, only mature oocytes were denuded and fertilized by intracytoplasmic sperm injection. Two day 3 embryos were transferred in most patients. Rates of oocyte maturation, cleavage, and pregnancy were compared.
RESULTS:
The oocyte maturation rates within 51 h were 62.6 and 72.7% in groups 1 and 2, respectively (p < 0.01). The embryo cleavage rate was significantly higher in group 2 than in group 1 (77.3 vs. 63.6%, p < 0.05). The pregnancy rate was higher in group 1 than in group 2 (50 vs. 30%, p > 0.05).
CONCLUSION:
FSH priming is beneficial for promotion of the maturation and quality of oocytes, leading to a higher embryo cleavage rate and lower rate of pregnancy loss.
AuthorsRoungsin Choavaratana, Isarin Thanaboonyawat, Pitak Laokirkkiat, Japarath Prechapanich, Singpetch Suksompong, Orawan Mekemaharn, Somsin Petyim
JournalGynecologic and obstetric investigation (Gynecol Obstet Invest) Vol. 79 Issue 3 Pg. 153-9 ( 2015) ISSN: 1423-002X [Electronic] Switzerland
PMID25503808 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Copyright© 2014 S. Karger AG, Basel.
Chemical References
  • Chorionic Gonadotropin
  • Progesterone
  • Follicle Stimulating Hormone
Topics
  • Adolescent
  • Adult
  • Chorionic Gonadotropin (administration & dosage, therapeutic use)
  • Female
  • Fertilization in Vitro (methods)
  • Follicle Stimulating Hormone (therapeutic use)
  • Humans
  • In Vitro Oocyte Maturation Techniques (methods)
  • Infertility, Female (drug therapy, therapy)
  • Polycystic Ovary Syndrome (drug therapy, physiopathology, therapy)
  • Pregnancy
  • Pregnancy Rate
  • Progesterone (administration & dosage, therapeutic use)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: